We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 256

New infringement lawsuit filed to protect BRCA1 and BRCA2 patents
  • Shook Hardy & Bacon LLP
  • USA
  • June 26 2014

Myriad Genetics has brought a new infringement lawsuit against a company offering a next-generation sequencing test that analyzes the BRCA1 and BRCA2


USPTO proposes changes to patent term adjustment
  • Shook Hardy & Bacon LLP
  • USA
  • June 26 2014

In response to the Federal Circuit Court of Appeals ruling in Novartis AG v. Lee, summarized in Issue 71 of this Bulletin, the U.S. Patent and


Federal court upholds FTC rules on reporting certain pharma patent transfers
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2014

Granting the agency's motion for summary judgment, a federal court in the District of Columbia has upheld the U.S. Federal Trade Commission's (FTC's


SCOTUS reverses Federal Circuit patent ruling
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2014

The U.S. Supreme Court has reversed a Federal Circuit Court of Appeals decision on induced infringement, ruling that a defendant cannot be


Court finds no standing for Consumer Watchdog in stem cell patent appeal
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2014

The Federal Circuit Court of Appeals has rejected not-for-profit Consumer Watchdog's appeal of the U.S. Patent and Trademark Office's (USPTO's


Financial statements don’t count
  • Shook Hardy & Bacon LLP
  • USA
  • August 9 2013

In Carolina Waterworks, the district court said Defendant’s financial statements were irrelevant to Plaintiff’s infringement damages theories


“Commercial manufacture” doesn’t require sale
  • Shook Hardy & Bacon LLP
  • USA
  • August 9 2013

In Astra, the court rejected Defendant’s attempts to avoid damages for batches of a pharmaceutical product it made, even though the drugs were never


Fork over the forecasts
  • Shook Hardy & Bacon LLP
  • USA
  • August 9 2013

An accused infringer’s attempts to block discovery of sales and volume forecasts proved unsuccessful when the district court in Linear Group Services


Second Circuit antitrust decision creates uncer tainty for non-practice of patents
  • Shook Hardy & Bacon LLP
  • USA
  • June 11 2015

The U.S. Court of Appeals for the Second Circuit's recent decision in New York v. Actavis PLC appeared on its face to address a narrow issue of


Company seeks SCOTUS order allowing Federal Circuit to apply Alice standard
  • Shook Hardy & Bacon LLP
  • USA
  • August 21 2014

Advanced Biological Laboratories SA (ABL) has requested in a reply brief that the U.S. Supreme Court (SCOTUS) issue a GVR ordergrant its